Janus Henderson Horizon Biotechnology Fund A2 HEUR
LU2441282972
Janus Henderson Horizon Biotechnology Fund A2 HEUR/ LU2441282972 /
NAV07/06/2024 |
Diferencia-0.1600 |
Tipo de beneficio |
Enfoque de la inversión |
Sociedad de fondos |
19.2200EUR |
-0.83% |
reinvestment |
Equity
Worldwide
|
Janus Henderson Inv. ▶ |
Estrategia de inversión
The Fund aims to provide capital growth over the long term.
The Fund invests at least 80% of its assets in shares (equities) and equity-related securities of companies, which are biotechnology or biotechnology-related, of any size, including smaller capitalisation companies, in any country. The Fund may also invest in other assets including bonds (including convertible bonds), preference shares, cash and money market instruments. The Investment Manager may use derivatives (complex financial instruments) with the aim of making investment gains in line with the Fund's objective, to reduce risk or to manage the Fund more efficiently.
Objetivo de inversión
The Fund aims to provide capital growth over the long term.
Datos maestros
Tipo de beneficio: |
reinvestment |
Categoría de fondos: |
Equity |
Región: |
Worldwide |
Sucursal: |
Sector Biotechnology |
Punto de referencia: |
NASDAQ Biotechnology Total Return Index |
Inicio del año fiscal: |
01/07 |
Última distribución: |
- |
Banco depositario: |
BNP Paribas Securities Services, Niederlassung Luxemburg |
País de origen: |
Luxembourg |
Permiso de distribución: |
Austria, Germany, Switzerland, Luxembourg |
Gestor de fondo: |
Andy Acker, Daniel Lyons, Agustin Mohedas |
Volumen de fondo: |
257.42 millones
USD
|
Fecha de fundación: |
25/02/2022 |
Enfoque de la inversión: |
- |
Condiciones
Recargo de emisión: |
5.00% |
Max. Comisión de administración: |
1.20% |
Inversión mínima: |
2,500.00 EUR |
Deposit fees: |
0.65% |
Cargo por amortización: |
1.00% |
Prospecto simplificado: |
- |
Sociedad de fondos
Fondos de empresa: |
Janus Henderson Inv. |
Dirección: |
201 Bishopsgate, EC2M 3AE, London |
País: |
United Kingdom |
Internet: |
www.janushenderson.com/
|
Activos
Stocks |
|
97.64% |
Bonds |
|
1.98% |
Cash |
|
0.37% |
Otros |
|
0.01% |
Países
United States of America |
|
66.88% |
United Kingdom |
|
5.20% |
Netherlands |
|
4.54% |
Denmark |
|
2.63% |
France |
|
2.60% |
China |
|
1.94% |
Virgin Islands (British) |
|
1.72% |
Cayman Islands |
|
1.19% |
Canada |
|
0.72% |
Cash |
|
0.37% |
Ireland |
|
0.13% |
Otros |
|
12.08% |
Sucursales
Pharma/Biotechnology |
|
83.25% |
Healthcare services |
|
1.51% |
Healthcare appliances |
|
0.83% |
Cash |
|
0.37% |
Otros |
|
14.04% |